Sulfasalazine-induced fulminant hepatitis in pediatric Crohn's disease: report of two cases.
Besnard
M
M
Service de Gastro-entérologie Pédiarique, Hôpital Robert Debré, Paris, France.
Debray
D
D
Durand
P
P
Cézard
J P
JP
Navarro
J
J
D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000601:surgery; D002648:Child; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D016031:Liver Transplantation; D008297:Male; D012460:Sulfasalazine / Q000009:adverse effects* / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D012460:Sulfasalazine